Table 1. E2 site DNA curvature in solution.
Insert (N4) | E2 site net curvaturea (°) | Curvature directionb (bp) |
---|---|---|
1(AATT) | 17.8 ± 1.2 | 22.26 ± 0.10 |
2(TTAA) | 11.2 ± 2.5 | 22.42 ± 0.01 |
3 (ACGT) | 1.2 ± 3.0 | 22.88 ± 0.06 |
4 | 0 | 22.45 ± 0.03 |
aDNA curvature relative to insert 4. Curvature estimates were obtained as described in Materials and Methods. Curve fitting of phasing data to equation 2 allowed extraction of a phasing amplitude for each construct. Using phasing amplitudes for phased A5 tract reference standards and an assumption of 18° curvature per A5 tract, amplitudes were converted to degrees of DNA curvature. The reported E2 site curvature was obtained by subtracting the absolute curvature of insert 4 (∼28°) from curvature estimates for inserts 1–4. Data are averages ± standard deviations based on two experiments.
bThe curvature direction is defined as the base pair spacing (arbitrary reference frame) separating the E2 test sequence in the insert duplex from the phased A5 tract array in the right phasing arms, that gives rise to the minimum mobility (maximum curvature, hence maximal alignment of loci of curvature). For A5 tract standards, this parameter has a value of 21.85 bp. The observation that this reference frame remains within ∼1 bp from the center of the E2 site indicates curvature in the expected direction. Deviation from the value of 21.85 bp observed for A5 tracts can also reflect a subtle difference in the helical repeat parameter for the E2 binding sequence relative to the corresponding sequence in insert 4.